Drugs / SH U04722
last change Oct 2007 re-read 3 minutes ago

SH U04722

Developed for
neoplasm
Investigated by
Bayer

Trials 1

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00375453 Jan → Oct 2007 neoplasm Bayer Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as SH U04722 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00375453 ↗